IA
BIIB icon

IndexIQ Advisors’s Biogen BIIB Stock Holding History

IndexIQ Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$636K Buy
3,014
+185
+7% +$40.2K 0.02% 353
2021
Q4 		$679K Buy
2,829
+241
+9% +$62K 0.02% 388
2021
Q3 		$732K Buy
2,588
+97
+4% +$31.8K 0.02% 365
2021
Q2 		$863K Buy
2,491
+49
+2% +$14.8K 0.03% 309
2021
Q1 		$683K Buy
2,442
+245
+11% +$66.1K 0.02% 316
2020
Q4 		$538K Buy
2,197
+991
+82% +$256K 0.02% 357
2020
Q3 		$342K Buy
1,206
+694
+136% +$194K 0.01% 368
2020
Q2 		$137K Buy
512
+450
+726% +$135K 0.01% 808
2020
Q1 		$20K Sell
62
-17,685
-100% -$5.37M ﹤0.01% 791
2019
Q4 		$5.27M Buy
17,747
+3,896
+28% +$1.08M 0.19% 85
2019
Q3 		$3.23M Sell
13,851
-4,728
-25% -$1.1M 0.11% 145
2019
Q2 		$4.34M Sell
18,579
-522
-3% -$121K 0.13% 130
2019
Q1 		$4.51M Sell
19,101
-6,489
-25% -$2.04M 0.13% 90
2018
Q4 		$7.7M Buy
25,590
+9,301
+57% +$2.97M 0.22% 75
2018
Q3 		$5.75M Sell
16,289
-8,248
-34% -$2.84M 0.19% 78
2018
Q2 		$7.12M Buy
24,537
+8,165
+50% +$2.3M 0.22% 79
2018
Q1 		$4.48M Buy
+16,372
New +$5.08M 0.14% 92

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

IndexIQ Advisors's BIIB Position: Q1 2022 in Review

IndexIQ Advisors increased its Biogen (BIIB) stake by 6.5% in Q1 2022, buying an estimated $40.2K and bringing the position to 3,014 shares worth $636K. The position accounts for 0.02% of the portfolio, ranked #353.

IndexIQ Advisors first reported a position in BIIB in Q1 2018 and has held it in 17 quarters since. The position peaked at $7.7M in Q4 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • IndexIQ Advisors held 3,014 shares of Biogen worth $636K as of Q1 2022.
  • IndexIQ Advisors bought 185 Biogen shares in Q1 2022, an estimated $40.2K.
  • Biogen made up 0.02% of IndexIQ Advisors's portfolio in Q1 2022, its #353 holding.
  • IndexIQ Advisors first reported a position in Biogen in Q1 2018 and has held it in 17 quarters since.
  • IndexIQ Advisors's Biogen position peaked at $7.7M in Q4 2018.
  • 951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.